The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Virtus LifeSci Biotech Products ETF BBP
Morningstar’s Analysis BBP
Will BBP outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Mirum Pharmaceuticals Inc | 2.23 | 498,327 | Healthcare |
Alnylam Pharmaceuticals Inc | 2.19 | 489,557 | Healthcare |
Kiniksa Pharmaceuticals International PLC Class A | 2.03 | 454,876 | Healthcare |
Legend Biotech Corp ADR | 1.99 | 446,034 | Healthcare |
Travere Therapeutics Inc Ordinary Shares | 1.99 | 444,437 | Healthcare |
Ligand Pharmaceuticals Inc | 1.92 | 429,234 | Healthcare |
Lexicon Pharmaceuticals Inc | 1.87 | 419,335 | Healthcare |
Ionis Pharmaceuticals Inc | 1.86 | 415,347 | Healthcare |
ACADIA Pharmaceuticals Inc | 1.81 | 404,872 | Healthcare |
Day One Biopharmaceuticals Inc | 1.81 | 404,797 | Healthcare |